LENZ Therapeutics's market cap is currently $1.20B. The company's EPS TTM is $-0.53; its P/E ratio is ―; LENZ Therapeutics is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.
